

The First Steps Toward Commercialization: IP and Funding
IP and Funding for University Research Commercialization
Join University of Pittsburgh and Carnegie Mellon University for two practical conversations on what it takes to move university research toward commercialization.
Both panels will be moderated by Kelly Collier, Director of Ecosystem Development, LifeX.
Doors open at 3:30 PM. Feel free to come, network, and get settled for the panels that will being at 4:00 PM.
4:00–4:30 PM | IP: Is Your Technology Commercially Meaningful?
What makes a technology commercially meaningful, not just patentable?
How do corporate and VCs evaluate emerging university technologies?
What are the biggest gaps between invention disclosure and commercialization?
Hear from experts who evaluate university technologies from licensing, investment, and industry partnership perspectives.
Jacob P. Greenberg, Senior Manager, Business Development & Licensing, Carnegie Mellon University
Maximilian von Poelnitz, GP, Foothill Ventures
Scott Morley, Senior Director, Office of Industry & Economic Partnerships, University of Pittsburgh
4:30–5:00 PM | Funding: What Will Fund the Next Milestone?
What types of funding are available to researchers?
What evidence, validation, or milestones make a technology more fundable?
How should researchers decide between grants, translational funding, and private capital?
Hear from researchers who have raised funding and the decision-makers who evaluate and allocate funding:
Dr. Carl Snyderman, Professor of Otolaryngology and Neurological Surgery at the University of Pittsburgh School of Medicine and Otolaryngology Director of the UPMC Center for Cranial Base Surgery
Cindy Chepanoske, Director, Center for Technology and Enterprise Creation at Carnegie Mellon University
Jordyn Ting, Postdoctoral associate in the Department of Physical Medicine and Rehabilitation at the University of Pittsburgh
Lauren Cantor Wright, Principal, Yosemite
The discussion will include practical examples of what helped technologies move forward, what caused them to stall, and what researchers can do next.